Haleon plc American Depositary Shares (Each representing two Ordinary Shares) (HLN)
9.6300
0.00 (0.00%)
![](https://www.marketbeat.com/logos/articles/med_20241007081635_pfizer-4-reasons-to-get-back-in-this-value-stock.jpg)
Pfizer Inc. (NYSEPFE) hit its peak during the COVID-19 pandemic when its vaccines developed with BioNTech SE NASDAQ: BNTXNASDAQBNTX)
Via MarketBeat · October 7, 2024
![](https://mms.businesswire.com/media/20240626898799/en/2170943/22/Nicotinell-picture-1.jpg)
Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; along with its subsidiaries together referred to as “Dr. Reddy’s”), a global pharmaceutical company, today announced that its subsidiary Dr. Reddy's Laboratories SA has signed a definitive agreement with Haleon plc (LSE/NYSE: HLN; “Haleon”), a leading consumer healthcare company, for purchase of shares of Northstar Switzerland SARL, a Haleon group company, to acquire Haleon’s global portfolio of consumer healthcare brands in the Nicotine Replacement Therapy (“NRT”) category outside of the United States. The portfolio to be acquired consists of Nicotinell, a global leader in the NRT category with an extensive footprint in over 30 countries spanning Europe, Asia including Japan, and Latin America, and local market-leading brand names of the product – Nicabate in Australia, Thrive in Canada, and Habitrol in New Zealand and Canada. The proposed acquisition will be inclusive of all formats such as lozenge, patch, gum as well as pipeline products, in all applicable global markets outside of the United States.
By Dr. Reddy’s Laboratories Ltd. · Via Business Wire · June 26, 2024
![](https://www.marketbeat.com/logos/articles/med_20231207093359_3-cheap-stock-ing-stuffers-wall-street-is-bullish.jpg)
These three companies have Wall Street feeling bullish and are trading under $10, making them ideal ‘stock'-ing stuffers for hard to shop for traders.
Via MarketBeat · December 7, 2023
![](https://ml.globenewswire.com/media/6a541874-83d3-44da-a17a-ef65464a84fd/small/haleon-png.png)
LONDON, Nov. 21, 2023 (GLOBE NEWSWIRE) -- More than three in five people worldwide experience health exclusion, with vulnerable and younger populations the worst affected, according to phase two of the global Health Inclusivity Index from Economist Impact, supported by consumer health company Haleon.
By Haleon · Via GlobeNewswire · November 20, 2023
![](https://ml.globenewswire.com/media/6a7ccd37-92e6-4d6a-b74f-369516b954e8/small/haleon-png.png)
LONDON, Sept. 28, 2023 (GLOBE NEWSWIRE) -- A new study of 18,097 people across 18 countries has discovered that society has grown less tolerant of people in pain, despite the effects of COVID-19 boosting global health awareness.
By Haleon · Via GlobeNewswire · September 28, 2023
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
This press release shall not constitute an offer to sell or the solicitation of an offer to buy any securities nor will there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction.
Via ACCESSWIRE · March 2, 2023